Table of Content

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview
4.1. Introduction
4.2. Primary Cells Market, by Region

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing acceptance in drug screening and cell based assays
5.1.1.2. Advantages of primary human cells over other existing methods
5.1.1.3. Growing focus on monoclonal antibodies and personalized medicine
5.1.2. Restraints
5.1.2.1. Common cell culture problems such as contamination
5.1.3. Opportunities
5.1.3.1. Expanding biotechnology and biopharmaceutical industries
5.1.3.2. Advancements in biomedical research using primary cells
5.1.4. Challenges
5.1.4.1. Ethical issues in cell biology research field
5.2. Market Segmentation Analysis
5.2.1. Origin: Increasing preference for human primary cells for accurate representations of human cellular responses
5.2.2. Cell Type: Rising adoption of dermatocytes in drug development and toxicity testing
5.2.3. End-User: Proliferating use of primary cells in life science companies to ensure accurate results during experimentation
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework

6. Primary Cells Market, by Origin
6.1. Introduction
6.2. Animal Primary Cells
6.3. Human Primary Cells

7. Primary Cells Market, by Cell Type
7.1. Introduction
7.2. Dermatocytes
7.3. Gastrointestinal Cells
7.4. Heart Cells
7.5. Hematopoietic Cells
7.6. Hepatocytes
7.7.1. Cryopreserved Hepatocytes
7.7.2. Fresh Hepatocytes
7.7. Lung Cells
7.8. Musculoskeletal Cells
7.9. Renal Cells

8. Primary Cells Market, by End-User
8.1. Introduction
8.2. Life Science Companies
8.3. Research Institutes

9. Americas Primary Cells Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States

10. Asia-Pacific Primary Cells Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam

11. Europe, Middle East & Africa Primary Cells Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom

12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.2. Market Share Analysis, By Key Player
12.3. Competitive Scenario Analysis, By Key Player
12.3.1. Merger & Acquisition
12.3.1.1. AnaBios Acquires Cell Systems, Expands Human Cell Portfolio for Drug Discovery
12.3.2. Agreement, Collaboration, & Partnership
12.3.2.1. CN Bio and LifeNet Health LifeSciences Partner to Supply Validated Primary Human Cells for Microphysiological Systems
12.3.3. New Product Launch & Enhancement
12.3.3.1. Human Cell Design Launches Endoc-BH5, an Advanced Human Beta Cell Model enabling New Discoveries in Type 1 and 2 Diabetes Research

13. Competitive Portfolio
13.1. Key Company Profiles
13.1.1. Biopredic International
13.1.2. Corning Incorporated
13.1.3. Danaher Corporation
13.1.4. FUJIFILM Irvine Scientific, Inc.
13.1.5. Lonza AG
13.1.6. PromoCell GmbH
13.1.7. Reachbio LLC
13.1.8. Sciencell Research Laboratories, Inc.
13.1.9. Sekisui Xenotech, LLC
13.1.10. Stem Cell Technologies, Inc.
13.1.11. StemExpress, LLC
13.1.12. The Bio Convergence Company
13.1.13. The Merck Group
13.1.14. Thermo Fisher Scientific, Inc.
13.1.15. Zenbio, Inc.
13.2. Key Product Portfolio

14. Appendix
14.1. Discussion Guide
14.2. License & Pricing



List of Figures

FIGURE 1. PRIMARY CELLS MARKET RESEARCH PROCESS
FIGURE 2. PRIMARY CELLS MARKET SIZE, 2023 VS 2030
FIGURE 3. PRIMARY CELLS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. PRIMARY CELLS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. PRIMARY CELLS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. PRIMARY CELLS MARKET DYNAMICS
FIGURE 7. PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2023 VS 2030 (%)
FIGURE 8. PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2023 VS 2030 (%)
FIGURE 10. PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. PRIMARY CELLS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 12. PRIMARY CELLS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS PRIMARY CELLS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 14. AMERICAS PRIMARY CELLS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES PRIMARY CELLS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 16. UNITED STATES PRIMARY CELLS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC PRIMARY CELLS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC PRIMARY CELLS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA PRIMARY CELLS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA PRIMARY CELLS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. PRIMARY CELLS MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 22. PRIMARY CELLS MARKET SHARE, BY KEY PLAYER, 2023

List of Tables

TABLE 1. PRIMARY CELLS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018–2023
TABLE 3. PRIMARY CELLS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL PRIMARY CELLS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2018-2030 (USD MILLION)
TABLE 6. PRIMARY CELLS MARKET SIZE, BY ANIMAL PRIMARY CELLS, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. PRIMARY CELLS MARKET SIZE, BY HUMAN PRIMARY CELLS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 9. PRIMARY CELLS MARKET SIZE, BY DERMATOCYTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. PRIMARY CELLS MARKET SIZE, BY GASTROINTESTINAL CELLS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. PRIMARY CELLS MARKET SIZE, BY HEART CELLS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. PRIMARY CELLS MARKET SIZE, BY HEMATOPOIETIC CELLS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, 2018-2030 (USD MILLION)
TABLE 15. PRIMARY CELLS MARKET SIZE, BY CRYOPRESERVED HEPATOCYTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. PRIMARY CELLS MARKET SIZE, BY FRESH HEPATOCYTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. PRIMARY CELLS MARKET SIZE, BY LUNG CELLS, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. PRIMARY CELLS MARKET SIZE, BY MUSCULOSKELETAL CELLS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. PRIMARY CELLS MARKET SIZE, BY RENAL CELLS, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. PRIMARY CELLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 21. PRIMARY CELLS MARKET SIZE, BY LIFE SCIENCE COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. PRIMARY CELLS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. AMERICAS PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2018-2030 (USD MILLION)
TABLE 24. AMERICAS PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 25. AMERICAS PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, 2018-2030 (USD MILLION)
TABLE 26. AMERICAS PRIMARY CELLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 27. AMERICAS PRIMARY CELLS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 28. ARGENTINA PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2018-2030 (USD MILLION)
TABLE 29. ARGENTINA PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 30. ARGENTINA PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, 2018-2030 (USD MILLION)
TABLE 31. ARGENTINA PRIMARY CELLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 32. BRAZIL PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2018-2030 (USD MILLION)
TABLE 33. BRAZIL PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 34. BRAZIL PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, 2018-2030 (USD MILLION)
TABLE 35. BRAZIL PRIMARY CELLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 36. CANADA PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2018-2030 (USD MILLION)
TABLE 37. CANADA PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 38. CANADA PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, 2018-2030 (USD MILLION)
TABLE 39. CANADA PRIMARY CELLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 40. MEXICO PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2018-2030 (USD MILLION)
TABLE 41. MEXICO PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 42. MEXICO PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, 2018-2030 (USD MILLION)
TABLE 43. MEXICO PRIMARY CELLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 44. UNITED STATES PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2018-2030 (USD MILLION)
TABLE 45. UNITED STATES PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 46. UNITED STATES PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, 2018-2030 (USD MILLION)
TABLE 47. UNITED STATES PRIMARY CELLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 48. UNITED STATES PRIMARY CELLS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 49. ASIA-PACIFIC PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2018-2030 (USD MILLION)
TABLE 50. ASIA-PACIFIC PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 51. ASIA-PACIFIC PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, 2018-2030 (USD MILLION)
TABLE 52. ASIA-PACIFIC PRIMARY CELLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 53. ASIA-PACIFIC PRIMARY CELLS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 54. AUSTRALIA PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2018-2030 (USD MILLION)
TABLE 55. AUSTRALIA PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 56. AUSTRALIA PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, 2018-2030 (USD MILLION)
TABLE 57. AUSTRALIA PRIMARY CELLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 58. CHINA PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2018-2030 (USD MILLION)
TABLE 59. CHINA PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 60. CHINA PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, 2018-2030 (USD MILLION)
TABLE 61. CHINA PRIMARY CELLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 62. INDIA PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2018-2030 (USD MILLION)
TABLE 63. INDIA PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 64. INDIA PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, 2018-2030 (USD MILLION)
TABLE 65. INDIA PRIMARY CELLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 66. INDONESIA PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2018-2030 (USD MILLION)
TABLE 67. INDONESIA PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 68. INDONESIA PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, 2018-2030 (USD MILLION)
TABLE 69. INDONESIA PRIMARY CELLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 70. JAPAN PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2018-2030 (USD MILLION)
TABLE 71. JAPAN PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 72. JAPAN PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, 2018-2030 (USD MILLION)
TABLE 73. JAPAN PRIMARY CELLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 74. MALAYSIA PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2018-2030 (USD MILLION)
TABLE 75. MALAYSIA PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 76. MALAYSIA PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, 2018-2030 (USD MILLION)
TABLE 77. MALAYSIA PRIMARY CELLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 78. PHILIPPINES PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2018-2030 (USD MILLION)
TABLE 79. PHILIPPINES PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 80. PHILIPPINES PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, 2018-2030 (USD MILLION)
TABLE 81. PHILIPPINES PRIMARY CELLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 82. SINGAPORE PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2018-2030 (USD MILLION)
TABLE 83. SINGAPORE PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 84. SINGAPORE PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, 2018-2030 (USD MILLION)
TABLE 85. SINGAPORE PRIMARY CELLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 86. SOUTH KOREA PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2018-2030 (USD MILLION)
TABLE 87. SOUTH KOREA PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 88. SOUTH KOREA PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, 2018-2030 (USD MILLION)
TABLE 89. SOUTH KOREA PRIMARY CELLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 90. TAIWAN PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2018-2030 (USD MILLION)
TABLE 91. TAIWAN PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 92. TAIWAN PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, 2018-2030 (USD MILLION)
TABLE 93. TAIWAN PRIMARY CELLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 94. THAILAND PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2018-2030 (USD MILLION)
TABLE 95. THAILAND PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 96. THAILAND PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, 2018-2030 (USD MILLION)
TABLE 97. THAILAND PRIMARY CELLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 98. VIETNAM PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2018-2030 (USD MILLION)
TABLE 99. VIETNAM PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 100. VIETNAM PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, 2018-2030 (USD MILLION)
TABLE 101. VIETNAM PRIMARY CELLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 102. EUROPE, MIDDLE EAST & AFRICA PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2018-2030 (USD MILLION)
TABLE 103. EUROPE, MIDDLE EAST & AFRICA PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 104. EUROPE, MIDDLE EAST & AFRICA PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, 2018-2030 (USD MILLION)
TABLE 105. EUROPE, MIDDLE EAST & AFRICA PRIMARY CELLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 106. EUROPE, MIDDLE EAST & AFRICA PRIMARY CELLS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 107. DENMARK PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2018-2030 (USD MILLION)
TABLE 108. DENMARK PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 109. DENMARK PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, 2018-2030 (USD MILLION)
TABLE 110. DENMARK PRIMARY CELLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 111. EGYPT PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2018-2030 (USD MILLION)
TABLE 112. EGYPT PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 113. EGYPT PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, 2018-2030 (USD MILLION)
TABLE 114. EGYPT PRIMARY CELLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 115. FINLAND PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2018-2030 (USD MILLION)
TABLE 116. FINLAND PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 117. FINLAND PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, 2018-2030 (USD MILLION)
TABLE 118. FINLAND PRIMARY CELLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 119. FRANCE PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2018-2030 (USD MILLION)
TABLE 120. FRANCE PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 121. FRANCE PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, 2018-2030 (USD MILLION)
TABLE 122. FRANCE PRIMARY CELLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 123. GERMANY PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2018-2030 (USD MILLION)
TABLE 124. GERMANY PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 125. GERMANY PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, 2018-2030 (USD MILLION)
TABLE 126. GERMANY PRIMARY CELLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 127. ISRAEL PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2018-2030 (USD MILLION)
TABLE 128. ISRAEL PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 129. ISRAEL PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, 2018-2030 (USD MILLION)
TABLE 130. ISRAEL PRIMARY CELLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 131. ITALY PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2018-2030 (USD MILLION)
TABLE 132. ITALY PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 133. ITALY PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, 2018-2030 (USD MILLION)
TABLE 134. ITALY PRIMARY CELLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 135. NETHERLANDS PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2018-2030 (USD MILLION)
TABLE 136. NETHERLANDS PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 137. NETHERLANDS PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, 2018-2030 (USD MILLION)
TABLE 138. NETHERLANDS PRIMARY CELLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 139. NIGERIA PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2018-2030 (USD MILLION)
TABLE 140. NIGERIA PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 141. NIGERIA PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, 2018-2030 (USD MILLION)
TABLE 142. NIGERIA PRIMARY CELLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 143. NORWAY PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2018-2030 (USD MILLION)
TABLE 144. NORWAY PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 145. NORWAY PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, 2018-2030 (USD MILLION)
TABLE 146. NORWAY PRIMARY CELLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 147. POLAND PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2018-2030 (USD MILLION)
TABLE 148. POLAND PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 149. POLAND PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, 2018-2030 (USD MILLION)
TABLE 150. POLAND PRIMARY CELLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 151. QATAR PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2018-2030 (USD MILLION)
TABLE 152. QATAR PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 153. QATAR PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, 2018-2030 (USD MILLION)
TABLE 154. QATAR PRIMARY CELLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 155. RUSSIA PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2018-2030 (USD MILLION)
TABLE 156. RUSSIA PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 157. RUSSIA PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, 2018-2030 (USD MILLION)
TABLE 158. RUSSIA PRIMARY CELLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 159. SAUDI ARABIA PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2018-2030 (USD MILLION)
TABLE 160. SAUDI ARABIA PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 161. SAUDI ARABIA PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, 2018-2030 (USD MILLION)
TABLE 162. SAUDI ARABIA PRIMARY CELLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 163. SOUTH AFRICA PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2018-2030 (USD MILLION)
TABLE 164. SOUTH AFRICA PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 165. SOUTH AFRICA PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, 2018-2030 (USD MILLION)
TABLE 166. SOUTH AFRICA PRIMARY CELLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 167. SPAIN PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2018-2030 (USD MILLION)
TABLE 168. SPAIN PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 169. SPAIN PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, 2018-2030 (USD MILLION)
TABLE 170. SPAIN PRIMARY CELLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 171. SWEDEN PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2018-2030 (USD MILLION)
TABLE 172. SWEDEN PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 173. SWEDEN PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, 2018-2030 (USD MILLION)
TABLE 174. SWEDEN PRIMARY CELLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 175. SWITZERLAND PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2018-2030 (USD MILLION)
TABLE 176. SWITZERLAND PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 177. SWITZERLAND PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, 2018-2030 (USD MILLION)
TABLE 178. SWITZERLAND PRIMARY CELLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 179. TURKEY PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2018-2030 (USD MILLION)
TABLE 180. TURKEY PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 181. TURKEY PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, 2018-2030 (USD MILLION)
TABLE 182. TURKEY PRIMARY CELLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 183. UNITED ARAB EMIRATES PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2018-2030 (USD MILLION)
TABLE 184. UNITED ARAB EMIRATES PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 185. UNITED ARAB EMIRATES PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, 2018-2030 (USD MILLION)
TABLE 186. UNITED ARAB EMIRATES PRIMARY CELLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 187. UNITED KINGDOM PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2018-2030 (USD MILLION)
TABLE 188. UNITED KINGDOM PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
TABLE 189. UNITED KINGDOM PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, 2018-2030 (USD MILLION)
TABLE 190. UNITED KINGDOM PRIMARY CELLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 191. PRIMARY CELLS MARKET, FPNV POSITIONING MATRIX, 2023
TABLE 192. PRIMARY CELLS MARKET SHARE, BY KEY PLAYER, 2023
TABLE 193. PRIMARY CELLS MARKET LICENSE & PRICING